ArticleCell reports. Medicine2024

Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.

Kristina R Edwards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.